13,14-Dihydro PGE1

13,14-Dihydro PGE1 is a metabolite of PGE1 (Prostaglandin E1) which inhibits the ADP-induced platelet aggregation (ID50 = 10.8 ng/mL platelet rich plasma) [1].

Product Specifications

CAS Number

[19313-28-1]

Product Name Alternative

13,14-Dihydroprostaglandin E1

UNSPSC

12352211

Hazard Statement

H225-H319-H336

Target

Endogenous Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/13-14-dihydro-pge1.html

Solubility

10 mM in DMSO

Smiles

OC(CCCCCC[C@@H]1[C@H]([C@@H](CC1=O)O)CC[C@@H](O)CCCCC)=O

Molecular Formula

C20H36O5

Molecular Weight

356.50

Precautions

P210-P233-P240-P241-P242-P243-P261-P264-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P370+P378-P403+P233-P403+P235-P405-P501

References & Citations

[1]Katzenschlager R, et al. Synergism between PGE1-metabolites (13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation. Prostaglandins Leukot Essent Fatty Acids. 1992 Mar;45 (3) :207-10.